Compare ANGI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGI | BDSX |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.7M | 276.2M |
| IPO Year | 2017 | 2020 |
| Metric | ANGI | BDSX |
|---|---|---|
| Price | $5.51 | $28.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $17.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 716.3K | 90.0K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1242.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $736,386,000.00 | $88,499,000.00 |
| Revenue This Year | $3.25 | $25.26 |
| Revenue Next Year | $3.76 | $19.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 47.60 | 24.08 |
| 52 Week Low | $4.26 | $5.26 |
| 52 Week High | $16.97 | $31.31 |
| Indicator | ANGI | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 61.34 | 57.31 |
| Support Level | $4.55 | $19.26 |
| Resistance Level | $6.52 | $31.31 |
| Average True Range (ATR) | 0.29 | 1.67 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 89.52 | 68.92 |
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.